Statement of Consolidated Cash Flows (unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net income	$ 181	$ 155
Adjustments to reconcile net income to cash provided from (used for) operations:
Depreciation and amortization	203	271
Deferred income taxes	24	25
Restructuring and other charges	22	148
Net loss from investing activities—asset sales	7	6
Net periodic pension cost	13	42
Stock-based compensation	28	35
Loss on debt redemption	141	64
Other	28	(1)
Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments:
Increase in receivables	(382)	(117)
Decrease (increase) in inventories	49	(42)
Decrease in prepaid expenses and other current assets	6	1
Increase (decrease) in accounts payable, trade	63	(439)
Decrease in accrued expenses	(121)	(177)
(Decrease) increase in taxes, including income taxes	(15)	41
Pension contributions	(68)	(110)
Increase in noncurrent assets	(1)	(5)
Decrease in noncurrent liabilities	(32)	(39)
Cash provided from (used for) operations	146	(142)
Financing Activities
Net change in short-term borrowings (original maturities of three months or less)	0	(8)
Additions to debt (original maturities greater than three months)	700	2,400
Payments on debt (original maturities greater than three months)	(1,491)	(2,041)
Debt issuance costs	(11)	(61)
Premiums paid on early redemption of debt	(133)	(59)
Proceeds from exercise of employee stock options	17	30
Dividends paid to shareholders	(11)	(10)
Repurchase of common stock	(225)	(51)
Net cash transferred to Arconic Corporation at separation	0	(500)
Other	(20)	(39)
Cash used for financing activities	(1,174)	(339)
Investing Activities
Capital expenditures	(138)	(220)
Proceeds from the sale of assets and businesses	8	114
Sale of debt securities	5	0
Cash receipts from sold receivables	267	258
Other	2	0
Cash provided from investing activities	144	152
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1)	(6)
Net change in cash, cash equivalents and restricted cash	(885)	(335)
Cash, cash equivalents and restricted cash at beginning of period	1,611	1,703
Cash, cash equivalents and restricted cash at end of period	$ 726	$ 1,368